Discover CSANZ 2025
Welcome to the microsite for the Cardiac Society of Australia and New Zealand (CSANZ) Congress, held in Brisbane on 14-17 August 2025.
Novartis Sponsored Symposium and Mini Orals
Details about the Novartis sponsored symposium and mini oral sessions during CSANZ.
Friday 15th August 2025
Novartis Breakfast Symposium: What Clinicians need to Know About Lp(a)
Time: 7:15am - 8:15am
Location: Mezzanine 1
Novartis Lunch Symposium: Case Conversations: Clinical Case Reviews in Complex ASCVD
Time: 12:30pm - 1:30pm
Location: Plaza 3
Speakers: Dr John Amarena, Dr Melissa Leung
Saturday 16th August 2025
Novartis Mini Oral: A year on...What's new for lp(a)
Time: 10:00am - 10:30am
Location: Theatrette 1
Novartis Mini Oral: "From Data to Action: ASCVD Audit Dashboard Review" Novartis x Magentus
Time: 3:00pm - 3:30pm
Location: Theatrette 1
Speaker: Dr Andrew Roy
Novartis Dinner Meeting
Register and find out more information about the Novartis CSANZ dinner meeting happening on Friday 15th August 2025
Date: Friday 15th August 2025
Time: 6:30 - 8:00pm
Location: "The Lex" Level 3, W Hotel Brisbane
Speakers: Dr Nick Lan, A/Prof Adam Nelson
Chair: A/Prof Karam Kostner
Novartis CSANZ Posters
Access the Novartis CSANZ posters presented at the Annual Scientific Meeting of the Cardiac Soceity of Australia and New Zealand (CSANZ)
Mini Oral Presentation
Title: LDL-C target attainment and statin use in patients with ASCVD, familial hypercholesterolemia, and those otherwise at moderate/high-risk of ASCVD in Australian general practice (SCOPE-GP)
Paper No. 929
Session Details: 06. Prevention
Mini Oral Session Time: 12:30 - 1:40pm
Presentation Time: 12:50 - 12:55pm
Presentation Order: 5
Presenting Author: Prof Gerald Watts
Dedicated Poster Session Time
5:40 - 6:30pm
Posters
Title: Real-world effectiveness, adherence and safety of inclisiran treatment in Belgian patients with atherosclerotic cardiovascular disease: The BE. REAL registry
Paper No: 478
Presenting Author: A/Prof John Amerena
Title: Effect of mild hepatic impairment on the pharmacokinetics of Pelacarsen
Paper No: 189
Presenting Author: A/Prof Timothy Tan
Title: Lp(a) testing and LDL-C levels among Australian ASCVD patients in 2022: a cross-sectional study from the Advara heartcare network (PREVAIL)
Paper No: 265
Presenting Author: Dr Jason Kaplan
Leqvio PBS Information: Authority Required (STREAMLINED) for patients with hypercholesterolaemia. Refer to PBS Schedule for full Authority information.
ENTRESTO PBS information: Authority required (STREAMLINED) for chronic heart failure. Refer to PBS Schedule for full Authority Information.